Chemotherapy-induced mast-cell degranulation constrains tertiary lymphoid maturation in lung cancer brain metastasis

BACKGROUND: Tertiary lymphoid structures (TLSs) support local adaptive immunity and are associated with favorable antitumor responses across multiple cancers. However, how anticancer treatment reshapes TLS maturation, particularly in lung cancer brain metastasis (LCBM), remains poorly understood. METHODS: We integrated clinicopathological profiling of LCBM cohorts with bulk and single-cell RNA sequencing, spatial profiling, immune-repertoire analysis, histological validation, and murine intracranial tumor models. Associations between prior treatment and TLS maturation were evaluated using multivariable analyses. Mechanistic studies examined chemotherapy-associated IL-33 release, mast-cell activation, and the effects of PGD2 on antigen-specific T-cell cytotoxicity and B-cell differentiation. Pharmacological inhibition of H-PGDS and mast-cell stabilization were further evaluated in vivo. RESULTS: Mature TLSs were associated with favorable survival in patients with LCBM, whereas preoperative chemotherapy was independently associated with impaired TLS maturation after adjustment for measured clinical and treatment covariates. Consistent with this observation, chemotherapy-treated tumors exhibited increased IL-33 levels, mast-cell accumulation, and enhanced mast-cell degranulation, with spatial analyses placing activated mast cells within TLS-associated immune niches. Mechanistically, IL-33 activated ST2-expressing mast cells, induced NF-κB-associated transcriptional programs. Functionally, mast cell-derived PGD2 suppressed antigen-specific CD8⁺ T-cell cytotoxicity and impaired plasma-cell differentiation, providing a potential link between chemotherapy and weakened local adaptive immunity. In vivo, pharmacological inhibition of H-PGDS enhanced chemotherapy efficacy, while mast-cell stabilization with cromolyn sodium reduced chemotherapy-associated degranulation, increased local adaptive immune-cell infiltration, improved intracranial tumor control, and prolonged survival when combined with chemotherapy. CONCLUSIONS: Our findings support a model in which chemotherapy-associated tissue stress activates an IL-33-responsive mast-cell program and restrains TLS-associated adaptive immunity in LCBM. Although this pathway is unlikely to operate as an exclusively linear or mast-cell-specific mechanism, targeting mast-cell-associated inflammatory signaling may provide a strategy to preserve antitumor immunity and improve the therapeutic efficacy of chemotherapy in brain metastasis.

Authors

Institutions

Publication Details

Journal
Journal of Hematology & Oncology
Published
2026-11-18
DOI
https://doi.org/10.1186/s13045-026-01869-5
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Chemotherapy-induced mast-cell degranulation constrains tertiary lymphoid maturation in lung cancer brain metastasis

Fufang Qiu, Licheng Zhang, Guichang Zeng, Muyuan You et al.
Journal of Hematology & Oncology
Cancer Immunotherapy and Biomarkers
article

Chemotherapy-induced mast-cell degranulation constrains tertiary lymphoid maturation in lung cancer brain metastasis

Fufang Qiu, Licheng Zhang, Guichang Zeng, Muyuan You, Yongqiang Ao, Ying Mao, Wei Hua, Yang Xing, Zhewei Shen, Minjie Fu
article en

Abstract

BACKGROUND: Tertiary lymphoid structures (TLSs) support local adaptive immunity and are associated with favorable antitumor responses across multiple cancers. However, how anticancer treatment reshapes TLS maturation, particularly in lung cancer brain metastasis (LCBM), remains poorly understood. METHODS: We integrated clinicopathological profiling of LCBM cohorts with bulk and single-cell RNA sequencing, spatial profiling, immune-repertoire analysis, histological validation, and murine intracranial tumor models. Associations between prior treatment and TLS maturation were evaluated using multivariable analyses. Mechanistic studies examined chemotherapy-associated IL-33 release, mast-cell activation, and the effects of PGD2 on antigen-specific T-cell cytotoxicity and B-cell differentiation. Pharmacological inhibition of H-PGDS and mast-cell stabilization were further evaluated in vivo. RESULTS: Mature TLSs were associated with favorable survival in patients with LCBM, whereas preoperative chemotherapy was independently associated with impaired TLS maturation after adjustment for measured clinical and treatment covariates. Consistent with this observation, chemotherapy-treated tumors exhibited increased IL-33 levels, mast-cell accumulation, and enhanced mast-cell degranulation, with spatial analyses placing activated mast cells within TLS-associated immune niches. Mechanistically, IL-33 activated ST2-expressing mast cells, induced NF-κB-associated transcriptional programs. Functionally, mast cell-derived PGD2 suppressed antigen-specific CD8⁺ T-cell cytotoxicity and impaired plasma-cell differentiation, providing a potential link between chemotherapy and weakened local adaptive immunity. In vivo, pharmacological inhibition of H-PGDS enhanced chemotherapy efficacy, while mast-cell stabilization with cromolyn sodium reduced chemotherapy-associated degranulation, increased local adaptive immune-cell infiltration, improved intracranial tumor control, and prolonged survival when combined with chemotherapy. CONCLUSIONS: Our findings support a model in which chemotherapy-associated tissue stress activates an IL-33-responsive mast-cell program and restrains TLS-associated adaptive immunity in LCBM. Although this pathway is unlikely to operate as an exclusively linear or mast-cell-specific mechanism, targeting mast-cell-associated inflammatory signaling may provide a strategy to preserve antitumor immunity and improve the therapeutic efficacy of chemotherapy in brain metastasis.

Journal of Hematology & OncologyVol. 19(1)
Shanghai Medical College of Fudan University (CN), Fudan University (CN), Zhongshan Hospital (CN), Huashan Hospital (CN), Shenzhen Medical Academy of Research and Translation (CN), Frontiers Center for Brain Science of the Ministry of Education (CN)
National Natural Science Foundation of China, Fudan University, Shanghai Medical College, Fudan University
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon